Page last updated: 2024-10-24

cefixime and Hematologic Neoplasms

cefixime has been researched along with Hematologic Neoplasms in 1 studies

Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.

Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Girmenia, C1
Russo, E1
Carmosino, I1
Breccia, M1
Dragoni, F1
Latagliata, R1
Mecarocci, S1
Morano, SG1
Stefanizzi, C1
Alimena, G1

Other Studies

1 other study available for cefixime and Hematologic Neoplasms

ArticleYear
Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
    Annals of hematology, 2007, Volume: 86, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Cefixime

2007